XML 53 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income before Provision for Income Tax
Income before provision for income taxes consisted of the following:
(in thousands)December 31, 2022December 31, 2021
United States$81,269 $43,645 
International(2,700)(1,555)
Income before provision for income taxes$78,569 $42,090 
Schedule of Federal and State Income Tax Expense
The federal and state income tax expense is summarized as follows:
(in thousands)December 31, 2022December 31, 2021
Current
Federal$— $— 
State
International— — 
Total current tax expense$$
Deferred
Federal$— $— 
State— — 
International— — 
Total deferred tax expense$— $— 
Total tax expense$$
Schedule of Deferred Tax Assets and Liabilities
The tax effects of significant items comprising the Company's deferred taxes are as follows:
(in thousands)December 31, 2022December 31, 2021
Deferred tax assets
Net operating loss carryforwards$27,210 $24,899 
Available for Sale Securities2,064 390 
Lease liability532 341 
Other1,580 230 
Fixed assets and intangibles25 89 
Capitalized research and development costs1,929 — 
Total deferred tax assets$33,340 $25,949 
Deferred tax liabilities
ROU asset$(515)$(344)
Fixed assets and intangibles(479)— 
Total deferred tax liabilities$(994)$(344)
Valuation allowance$(32,346)$(25,605)
Net deferred taxes$— $— 
Schedule of Effective Tax Rate
The effective tax rate of the Company's provision (benefit) for income taxes differs from the federal statutory rate as follows:
December 31, 2022December 31, 2021
Statutory rate21.0 %21.0 %
State tax1.1 (1.3)
Warrants, BCF, and other equity items(28.7)(33.3)
Valuation allowance6.4 15.6 
Other0.7 (0.2)
Foreign rate differential(0.2)(0.2)
Stock-based compensation(0.3)(1.6)
Total— %— %
The effective tax rate of the Company's provision (benefit) for income taxes differs from the federal statutory rate as follows:
December 31, 2022December 31, 2021
Statutory rate$16,500 $8,833 
State tax875 (563)
Warrants, BCF, and other equity items(22,559)(14,002)
Valuation allowance5,040 6,552 
Other502 (72)
Foreign rate differential(148)(85)
Stock-based compensation(207)(660)
Total$$